These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23568483)

  • 1. Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study.
    Contiero P; Berrino F; Tagliabue G; Mastroianni A; Di Mauro MG; Fabiano S; Annulli M; Muti P
    Breast Cancer Res Treat; 2013 Apr; 138(3):951-9. PubMed ID: 23568483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer.
    Caan BJ; Kwan ML; Hartzell G; Castillo A; Slattery ML; Sternfeld B; Weltzien E
    Cancer Causes Control; 2008 Dec; 19(10):1319-28. PubMed ID: 18752034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups.
    Holm JB; Baggesen E; Cronin-Fenton D; Frystyk J; Bruun JM; Christiansen P; Borgquist S
    Sci Rep; 2024 Jun; 14(1):14486. PubMed ID: 38914635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease.
    Minicozzi P; Berrino F; Sebastiani F; Falcini F; Vattiato R; Cioccoloni F; Calagreti G; Fusco M; Vitale MF; Tumino R; Sigona A; Budroni M; Cesaraccio R; Candela G; Scuderi T; Zarcone M; Campisi I; Sant M
    Eur J Cancer; 2013 Dec; 49(18):3881-8. PubMed ID: 24011933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
    Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
    Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients.
    Venturelli E; Orenti A; Fabricio ASC; Garrone G; Agresti R; Paolini B; Bonini C; Gion M; Berrino F; Desmedt C; Coradini D; Biganzoli E
    BMC Cancer; 2018 Jun; 18(1):651. PubMed ID: 29895278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis.
    Sun L; Zhu Y; Qian Q; Tang L
    Medicine (Baltimore); 2018 Jun; 97(26):e11220. PubMed ID: 29952978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.
    Ewertz M; Gray KP; Regan MM; Ejlertsen B; Price KN; Thürlimann B; Bonnefoi H; Forbes JF; Paridaens RJ; Rabaglio M; Gelber RD; Colleoni M; Láng I; Smith IE; Coates AS; Goldhirsch A; Mouridsen HT
    J Clin Oncol; 2012 Nov; 30(32):3967-75. PubMed ID: 23045588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study.
    Bahl M; Ennis M; Tannock IF; Hux JE; Pritchard KI; Koo J; Goodwin PJ
    Breast Cancer Res Treat; 2005 Nov; 94(2):135-44. PubMed ID: 16261412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.
    Kwan ML; Chen WY; Kroenke CH; Weltzien EK; Beasley JM; Nechuta SJ; Poole EM; Lu W; Holmes MD; Quesenberry CP; Pierce JP; Shu XO; Caan BJ
    Breast Cancer Res Treat; 2012 Apr; 132(2):729-39. PubMed ID: 22187127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
    Cantini L; Pistelli M; Merloni F; Fontana A; Bertolini I; De Angelis C; Bastianelli L; Della Mora A; Santinelli A; Savini A; Maccaroni E; Diodati L; Falcone A; Berardi R
    Clin Breast Cancer; 2020 Feb; 20(1):e89-e98. PubMed ID: 31378534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.
    Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ
    Cancer; 2017 Jul; 123(13):2535-2542. PubMed ID: 28295245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis.
    Wulaningsih W; Vahdaninia M; Rowley M; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Coolen AC; Van Hemelrijck M
    BMC Cancer; 2015 Nov; 15():913. PubMed ID: 26577580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting serum glucose level and cancer risk in Korean men and women.
    Jee SH; Ohrr H; Sull JW; Yun JE; Ji M; Samet JM
    JAMA; 2005 Jan; 293(2):194-202. PubMed ID: 15644546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer.
    Bergom C; Kelly T; Bedi M; Saeed H; Prior P; Rein LE; Szabo A; Wilson JF; Currey AD; White J
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):65-71. PubMed ID: 27511848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer.
    Warren LE; Ligibel JA; Chen YH; Truong L; Catalano PJ; Bellon JR
    Ann Surg Oncol; 2016 Nov; 23(12):3870-3879. PubMed ID: 27448118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low body mass index is an independent predictive factor of local recurrence after conservative treatment for breast cancer.
    Marret H; Perrotin F; Bougnoux P; Descamps P; Hubert B; Lefranc T; Le Floch O; Lansac J; Body G
    Breast Cancer Res Treat; 2001 Mar; 66(1):17-23. PubMed ID: 11368406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.
    Goodwin PJ; Ennis M; Pritchard KI; Trudeau ME; Koo J; Madarnas Y; Hartwick W; Hoffman B; Hood N
    J Clin Oncol; 2002 Jan; 20(1):42-51. PubMed ID: 11773152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.